Ruengies - I sold some today based on Gfp's concerns (thanks for your additional DD Gfp), I'm actually fairly comfortable with the trial side of it, it's the financing that has me concerned.
I'm smart enough to know how much I don't know when it comes to shrewd hedge funds and financing deals, and I'm wondering now if some aspect of this financing will actually keep CLSC from popping nearly as much as I was thinking it would if the trials were successful.
Since this is a "toxic" financing, will it somehow be in Cornell's "interests" to keep a lid on CLSC if the trials are successful?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.